Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × aflibercept × Clear all

Carcinoid Tumor, Neoplasm Metastasis

NCT02181556 2021-06-07

Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer

Phase 2 Completed

41 enrolled 8 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01669720 2020-02-17

C261

Phase 2 Terminated

10 enrolled 7 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03264274 2017-08-31

AUSCOR

Phase 2 Withdrawn

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01802684 2017-03-01

VELVET

Phase 2 Completed

49 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT02045030 2016-11-16

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

Phase 2 Terminated

14 enrolled

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT00851084 2016-06-07

AFFIRM

Phase 2 Completed

268 enrolled 16 charts

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00284141 2012-12-10

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Phase 2 Completed

98 enrolled 14 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Disease, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

Clinical Trials

Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors

Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer

C261

AUSCOR

VELVET

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

AFFIRM

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma